Psoriasis Clinical Trials
Psoriasis clinical trials study new biologics, small-molecule drugs, and treatment approaches for psoriasis and related immune or inflammatory conditions. Corterve gathers actively recruiting Psoriasis studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Psoriasis studies
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345PHASE1National Cancer Institute (NCI)Autoimmune DiseaseBirmingham, Alabama
- A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA TherapeuticallyNCT07654751PHASE4Janssen Research & Development, LLCPsoriasisChapel Hill, North Carolina
- A Study to Assess Deucravacitinib Safety in PregnancyNCT07017699Bristol-Myers SquibbPsoriasis (PsO)La Jolla, California
- An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail PsoriasisNCT07725822PHASE4Modern Research Associates, PLLCChronic Plaque PsoriasisDallas, Texas
- An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisNCT07449702PHASE2Oruka Therapeutics, Inc.Plaque PsoriasisPhoenix, Arizona
- Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)NCT07116967PHASE3Bristol-Myers SquibbPlaque PsoriasisBirmingham, Alabama
- Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque PsoriasisNCT07362017PHASE3Vanda PharmaceuticalsModerate-to-severe Chronic Plaque PsoriasisGlendale, Arizona
- Metabolic Profiling of Immune Responses in Immune-mediated DiseasesNCT04864886National Institute of Allergy and Infectious Diseases (NIAID)Primary ImmunodeficiencyBethesda, Maryland
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)NCT06888193PHASE1UCB Biopharma SRLModerate to Severe Plaque PsoriasisSanta Monica, California
- The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin DiseaseNCT07487831PHASE4University of California, San FranciscoAtopic Dermatitis (Eczema)San Francisco, California
- A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisNCT07250802PHASE3TakedaPlaque PsoriasisChula Vista, California
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)NCT06857942PHASE4Eli Lilly and CompanyPsoriasisPhoenix, Arizona
Psoriasis trials by state
Psoriasis trials by metro
Frequently asked questions
- How do I find recruiting Psoriasis clinical trials?
- Browse the actively recruiting Psoriasis studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Psoriasis clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Psoriasis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.